focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKenmare Resources Regulatory News (KMR)

Share Price Information for Kenmare Resources (KMR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 345.50
Bid: 345.00
Ask: 346.00
Change: -2.00 (-0.58%)
Spread: 1.00 (0.29%)
Open: 355.00
High: 355.00
Low: 340.00
Prev. Close: 347.50
KMR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of 2023 Annual Report

4 Apr 2024 07:00

Publication of 2023 Annual Report

Kenmare Resources plc (“Kenmare” or “the Company” or “the Group”)

4 April 2024

Publication of 2023 Annual Report

Kenmare Resources plc (LSE:KMR, ISE:KMR), one of the leading global producers of titanium minerals and zircon, which operates the Moma Titanium Minerals Mine (the "Mine" or "Moma") in northern Mozambique, today announces the publication and filing of its Annual Report for the year ended 31 December 2023.

The 2023 Annual Report (in ESEF-compliant and PDF formats) is available for inspection on the Company's website and can be downloaded here. It has also been submitted to Euronext Dublin and the UK National Storage Mechanism and will shortly be available for inspection at the following locations:

https://direct.euronext.com/#/oamfiling

and

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

The 2023 Annual Report is available to view directly by clicking on the link at the end of this announcement.

Paper copies are expected to be posted on 11 April 2024 to shareholders who have requested to receive them.

2023 key highlights

Financial

Recommended 2023 dividend of $50.0 million or USc56.04 per share, a 3% increase compared to 2022 (USc54.31), comprising an interim dividend of USc17.50 per share (paid in October 2023) and a final dividend of USc38.54 per share (payable in May 2024)Mineral product revenue of $437.1 million, a 12% decrease compared to 2022 ($498.3 million), driven by a 10% lower average price received for Kenmare’s products, due to weaker markets and a 3% reduction in shipmentsTotal cash operating costs of $228.1 million, up 4% on 2022 ($218.7 million), due to increased heavy mobile equipment rental, higher fuel costs, and costs associated with a severe lightning strike in Q1 2023Cash operating costs per tonne of $209, a 15% increase compared to 2022 ($182 per tonne), due to higher total cash operating costs and a 9% decrease in production of finished productsEBITDA of $220.3 million, representing a strong EBITDA margin of 50% (2022: 60%), despite weaker product pricing driving a 26% decrease on 2022 ($298.0 million)Profit after tax of $131.0 million, down 36% on 2022 ($206.0 million)Diluted earnings per share of $1.37 per share, a 35% decrease on 2022 ($2.12 per share)Net cash of $20.7 million at year-end 2023 (2022: $25.7 million), with cash and cash equivalents of $71.0 million (2022: $108.3 million)Share buy-back of 5.9% of Kenmare’s issued share capital for £23.6 million ($30.0 million) completed in September 2023Post-period end, new debt facilities agreed for a $200 million Revolving Credit Facility to enhance financial flexibility and support Kenmare’s planned capital programmes

Operational and corporate

As announced on 15 March 2024, Managing Director Michael Carvill will step down from his executive role and Board position later this year – the Nomination Committee has commenced a process to find his successorStrong safety performance achieved in Q4 2023 has continued in Q1 2024, with the milestone of three million hours without a Lost Time Injury passed in late FebruaryHeavy Mineral Concentrate (“HMC”) production of 1,448,300 tonnes in 2023, a 9% decrease compared to 2022 (1,586,200 tonnes), due to lower ore grades and mining rates impacted by power interruptions and a severe lightning strike in Q1 2023Ilmenite production of 986,300 tonnes in 2023, a 9% decrease on 2022 (1,088,300 tonnes), broadly in line with a 9% reduction in HMC processedShipments of finished products of 1,045,200 tonnes in 2023, a 3% decrease on 2022 (1,075,600 tonnes), due to weaker product markets and poor weather conditions in Q4 2023Ilmenite production guidance for 2024 is 950,000 to 1,050,000 tonnesProduction in 2024 will be second half weighted, with Q1 2024 production expected to be in line with Q1 2023 – material uplift in production expected in Q2 2024

For further information, please contact:

Kenmare Resources plcJeremy Dibb / Katharine Sutton / Michael StarkeInvestor Relationsir@kenmareresources.comTel: +353 1 671 0411Mob: +353 87 943 0367 / +353 87 663 0875

Murray (PR advisor)Paul O’Kanepokane@murraygroup.ieTel: +353 1 498 0300Mob: +353 86 609 0221

About Kenmare Resources

Kenmare Resources plc is one of the world's largest producers of mineral sands products. Listed on the London Stock Exchange and the Euronext Dublin, Kenmare operates the Moma Titanium Minerals Mine in Mozambique. Moma's production accounts for approximately 7% of global titanium feedstocks and the Company supplies to customers operating in more than 15 countries. Kenmare produces raw materials that are ultimately consumed in everyday quality-of life items such as paints, plastics, and ceramic tiles.

All monetary amounts refer to United States dollars unless otherwise indicated.

Attachment

2024-04-04 Kenmare 2023 Annual Report
Date   Source Headline
29th May 20237:00 amGNWDirector/PDMR Shareholding
11th May 20233:06 pmGNWResult of AGM
11th May 20233:03 pmGNWHolding(s) in Company
11th May 20237:00 amGNWBoard Update
11th May 20237:00 amGNWReport on Payments to Governments
5th May 20235:11 pmGNWHolding(s) in Company
2nd May 202312:06 pmGNWHolding(s) in Company
26th Apr 20237:00 amGNWCapital Markets Day
18th Apr 202312:00 pmGNWNotice of AGM
12th Apr 202312:00 pmGNWDirector/PDMR Shareholding
12th Apr 20237:00 amGNWQ1 2023 Production Report
11th Apr 20239:27 amGNWDirector/PDMR Shareholding
6th Apr 20237:00 amGNWPublication of 2022 Sustainability Report
6th Apr 20237:00 amGNWPublication of 2022 Annual Report
28th Mar 20234:30 pmGNWDirector/PDMR Shareholding
23rd Mar 20232:13 pmGNWHolding(s) in Company
22nd Mar 20237:00 amGNW2022 Preliminary Results
14th Mar 20231:16 pmGNWHolding(s) in Company
13th Mar 20232:04 pmGNWHolding(s) in Company
27th Feb 20239:56 amGNWHolding(s) in Company
27th Feb 20239:54 amGNWHolding(s) in Company
26th Jan 20237:00 amGNWBoard Update
18th Jan 20237:00 amGNWQ4 2022 Production Report and 2023 Guidance
16th Jan 20236:08 pmGNWHolding(s) in Company
9th Jan 20234:21 pmGNWHolding(s) in Company
9th Jan 20233:56 pmGNWHolding(s) in Company
22nd Dec 20224:35 pmGNWHolding(s) in Company
21st Dec 20225:07 pmGNWHolding(s) in Company
14th Dec 20227:00 amGNWBoard Update
1st Dec 20222:12 pmGNWDeirdre Somers appointed independent director of Enfusion, Inc.
25th Nov 20227:00 amGNWGuidance Update
9th Nov 20221:06 pmGNWHolding(s) in Company
18th Oct 20224:43 pmGNWHolding(s) in Company
14th Oct 202211:54 amGNWHolding(s) in Company
13th Oct 20227:00 amGNWQ3 2022 Production Report
4th Oct 20229:03 amGNWResults of Odd-lot Offer
30th Sep 202212:18 pmGNWDirector/PDMR Shareholding
30th Sep 20227:00 amGNWBoard Update
28th Sep 20221:45 pmGNWDirector/PDMR Shareholding
26th Sep 20222:22 pmGNWHolding(s) in Company
31st Aug 20224:01 pmGNWHolding(s) in Company
25th Aug 20227:00 amGNWAppointment of Financial Director / Directorate Change Announcement under LR 9.6.11
24th Aug 20227:00 amGNWLaunch of Odd-lot Offer and Finalisation of Offer Price
19th Aug 20224:44 pmGNWHolding(s) in Company
17th Aug 20227:00 amGNWHalf-Yearly Financial Report for the six months to 30 June 2022 and interim dividend
21st Jul 202212:00 pmGNWHolding(s) in Company
14th Jul 20227:00 amGNWQ2 and H1 2022 Production Report
7th Jun 20227:00 amGNWDirector/PDMR Shareholding
26th May 20226:13 pmGNWResult of AGM and Board Update
26th May 20227:00 amGNWReport on Payments to Governments 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.